Market Size of Global Cryostat Microbiome Equipment Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 6.89 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Cryostat Microbiome Equipment Market Analysis
The Cryostat Microbiome Equipment Market is projected to register a CAGR of 6.89% during the forecast period (2022 to 2027).
The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. The cryostat microtome equipment is widely used in diagnostic and research laboratories for the study of histopathology of tissues. COVID-19 had severely impacted the research on chronic diseases such as cancer. An article titled 'Impact of the COVID-19 Pandemic on Cancer Researchers: A Qualitative Study of Events to Inform Mitigation Strategies' published in the journal of Frontiers in Public Health in November 2021 discussed the impacts of the COVID-19 pandemic on cancer researchers. The article listed various factors such as financial resources, limited access to patients for research, decreased patient access to cancer care, staffing issues, administrative delays, or supply chain issues as the major limitations for the decline in the quantity of cancer research. Such a lack of trained personnel to handle cryostat microbiome equipment and disruptions in the supply chain is expected to have a significant impact on the growth of the market.
However, with the rise of the pandemic, increasing research in the immunohistochemistry of the COVID-19 infected tissues has positively impacted the growth of the cryostat microtome equipment market. For instance, an article presented in the Elsevier journal of Immunology in September 2021 titled 'Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy' studied the efficacy of neutralizing antibodies for COVID-19 treatment implemented the use of cryo-immunohistology of organs for further studies. Such an increase in the use of cryostat microtome equipment is expected to boost the growth of the market during the forecast period.
Major chronic diseases such as cancer, cardiovascular diseases, chronic lung disease, stroke, Alzheimer's, diabetes, and chronic kidney disease are on the rise all over the world, which is adding to the growth of the cryostat microbiome equipment market. Cancer is a leading cause of death all around the world, accounting for around 10 million deaths in 2020. According to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounts for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. According to the International Diabetes Federation Diabetes Atlas Tenth edition 2021, in 2021, around 537 million adults all over the world were found to have diabetes; with the numbers projected to grow to 643 million by 2030 and 783 million by 2045. The large population affected by chronic diseases and the increase in the necessity of cryostat microbiome equipment for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the cryostat microbiome equipment market.
Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period.
Cryostat Microbiome Equipment Industry Segmentation
As per the scope of this report, the cryostat microbiome equipment is a specialized precision cutting instrument that can accurately and repeatedly cut slices of sections from a block of embedded tissue at very low temperatures (around -20°C to -30°C). The cryostat microbiome equipment uses a cooling chamber for the cryofixation of the tissues to ensure speed and accurate slicing. The equipment is mostly used in diagnostic and research laboratories for the study of histopathology of tissues. The cryostat microbiome equipment market is segmented by Product (Manual Cryostat Microtome Equipment, Semi-automatic Cryostat Microtome Equipment and Automatic Microtome Cryostat Equipment), End User (Hospitals, Ambulatory Surgical Centers and Diagnostic & Research Laboratories) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Market report also covers the estimated market sizes and trends across major regions globally. The report offers values in (in USD million) for the above segments.
By Product | |
Manual Cryostat Microtome Equipment | |
Semi-automatic Cryostat Microtome Equipment | |
Automatic Microtome Cryostat Equipment |
End User | |
Hospitals | |
Ambulatory Surgical Centers | |
Diagnostic & Research Laboratories |
Geography | |
North America | |
Europe | |
Asia-Pacific | |
Middle-East and Africa | |
South America |
Global Cryostat Microbiome Equipment Market Size Summary
The Cryostat Microbiome Equipment Market is experiencing growth driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes globally. The equipment is essential in diagnostic and research laboratories for histopathological studies, particularly in the context of immunohistochemistry. The COVID-19 pandemic initially posed challenges by disrupting research and supply chains, but it also spurred interest in studying COVID-19 infected tissues, thereby positively impacting market growth. The demand for cryostat microbiome equipment is further fueled by the rising need for accurate and efficient diagnostic tools in the face of growing chronic disease cases, which necessitate advanced equipment for tissue analysis and treatment planning.
In North America, the market is bolstered by technological advancements and increased healthcare expenditure, which supports the adoption of innovative cryostat microbiome equipment. The region's high awareness of these advanced models contributes to its robust market growth. The fragmented market landscape features several key players, including Epredia, Histo-Line Laboratories, and Leica Microsystems, who are currently leading in market share. These companies are instrumental in driving the market forward through continuous innovation and development of advanced equipment. The ongoing investment in healthcare infrastructure and the rising necessity for efficient diagnostic tools are expected to sustain the market's growth trajectory in the coming years.
Global Cryostat Microbiome Equipment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Chronic Diseases
-
1.2.2 Rising Healthcare Expenditure
-
-
1.3 Market Restraints
-
1.3.1 Lack of Skilled Professionals
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Manual Cryostat Microtome Equipment
-
2.1.2 Semi-automatic Cryostat Microtome Equipment
-
2.1.3 Automatic Microtome Cryostat Equipment
-
-
2.2 End User
-
2.2.1 Hospitals
-
2.2.2 Ambulatory Surgical Centers
-
2.2.3 Diagnostic & Research Laboratories
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.2 Europe
-
2.3.3 Asia-Pacific
-
2.3.4 Middle-East and Africa
-
2.3.5 South America
-
-
Global Cryostat Microbiome Equipment Market Size FAQs
What is the current Global Cryostat Microbiome Equipment Market size?
The Global Cryostat Microbiome Equipment Market is projected to register a CAGR of 6.89% during the forecast period (2024-2029)
Who are the key players in Global Cryostat Microbiome Equipment Market?
Epredia , Histo-Line Laboratories S.R.L. , Leica Microsystems Nussloch GmbH , Sakura Finetek USA and Slee Medical GmbH are the major companies operating in the Global Cryostat Microbiome Equipment Market.